News
Pharnext Announces PXT3003 for the Treatment of Charcot-Marie-Tooth Disease Type 1A has Been Granted Promising Innovative Medicine (PIM) Designation by UK Medicines and Healthcare Products Regulatory Agency
Pharnext Announces PXT3003 for the Treatment of Charcot-Marie-Tooth Disease Type 1A has Been Granted Promising Innovative Medicine (PIM) Designation by UK Medicines and Healthcare Products Regulatory Agency
DGAP-News: Abivax 2019 Financial Results and Operations Update
DGAP-News: Abivax 2019 Financial Results and Operations Update
DGAP-News: Abivax veröffentlicht Finanzergebnisse für das Jahr 2019 und gibt Update zur Unternehmensentwicklung
DGAP-News: Abivax veröffentlicht Finanzergebnisse für das Jahr 2019 und gibt Update zur Unternehmensentwicklung
Showroomprive.com: Annual Results 2019 - Sharp impact of exceptional operations on stock (large clearance and depreciation)
Showroomprive.com: Annual Results 2019 - Sharp impact of exceptional operations on stock (large clearance and depreciation)
RUBIS : 2019 ANNUAL RESULTS
RUBIS : 2019 ANNUAL RESULTS
DGAP-News: Abivax 2020 Financial Communication Calendar
DGAP-News: Abivax 2020 Financial Communication Calendar
DGAP-News: Abivax Finanzkalender 2020
DGAP-News: Abivax Finanzkalender 2020
Kaufman & Broad SA: AMENDMENT OF THE MANDATE FOR THE SHARE BUYBACK PROGRAM
Kaufman & Broad SA: AMENDMENT OF THE MANDATE FOR THE SHARE BUYBACK PROGRAM
Pharnext raises € 7.7 million in a private placement
Pharnext raises € 7.7 million in a private placement
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
In Brazil, power sale contract with Braskem: Voltalia ready to build its biggest solar project - 270 megawatts
In Brazil, power sale contract with Braskem: Voltalia ready to build its biggest solar project - 270 megawatts
ALD closes sale of equity stake in ALD FORTUNE AUTO LEASING & RENTING in China
ALD closes sale of equity stake in ALD FORTUNE AUTO LEASING & RENTING in China
DGAP-News: Abivax Includes First Patient in U.S. Phase 1/2 Clinical Trial of ABX196 to Treat Hepatocellular Carcinoma
DGAP-News: Abivax Includes First Patient in U.S. Phase 1/2 Clinical Trial of ABX196 to Treat Hepatocellular Carcinoma
DGAP-News: Abivax schließt ersten Patienten in US-amerikanische klinische Phase-1/2-Studie mit ABX196 zur Behandlung des Leberzellkarzinoms ein
DGAP-News: Abivax schließt ersten Patienten in US-amerikanische klinische Phase-1/2-Studie mit ABX196 zur Behandlung des Leberzellkarzinoms ein
Kaufman & Broad SA: AMENDMENT OF THE MANDATE FOR THE SHARE BUYBACK PROGRAM
Kaufman & Broad SA: AMENDMENT OF THE MANDATE FOR THE SHARE BUYBACK PROGRAM
Voltalia acquires Greensolver and strengthens its services to third-party clients
Voltalia acquires Greensolver and strengthens its services to third-party clients
Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech SA: Information on Document Availability
ALD: ALD announces financial statements 2019
ALD: ALD announces financial statements 2019
RUBIS: Fourth quarter revenue up 12% - Volume growth and firm margins
RUBIS: Fourth quarter revenue up 12% - Volume growth and firm margins
Voltalia SA: total number of shares and voting rights in the share capital as of January 31, 2020
Voltalia SA: total number of shares and voting rights in the share capital as of January 31, 2020
Voltalia SA: Smartenergy retains Voltalia to build and maintain solar farms in Portugal totaling 134 megawatts
Voltalia SA: Smartenergy retains Voltalia to build and maintain solar farms in Portugal totaling 134 megawatts
RUBIS: Capital increase reserved for Group's employees
RUBIS: Capital increase reserved for Group's employees
ALD Q4 & FY 2019 results publication
ALD Q4 & FY 2019 results publication
ALD reports full year 2019 results
ALD reports full year 2019 results
ALD announces management changes
ALD announces management changes